Anavex Life Sciences (AVXL) Receivables - Other (2022 - 2026)
Anavex Life Sciences (AVXL) posted Receivables - Other of $800,000 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 33.3% from $600,000 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Anavex Life Sciences (AVXL) Receivables - Other (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Anavex Life Sciences' Receivables - Other came in at $700,000, down 69.6% from FY2024.
- Annual Receivables - Other has declined for three consecutive fiscal years, with a three-year compound annual growth rate of -37.7% (FY2022 to FY2025).
- In prior fiscal years, Anavex Life Sciences' Receivables - Other was $2.3 million in FY2024 (-8.0%), $2.5 million in FY2023 (-13.8%) and $2.9 million in FY2022.
- Quarterly Receivables - Other has run from a low of $500,000 in fiscal Q2 2025 to a high of $2.9 million in fiscal Q4 2022 over five years.
- On a year-over-year basis, Receivables - Other increased in two of the last five quarters, with an average decline of 11.0%.
- According to Business Quant data, Receivables - Other for the three prior fiscal quarters was $800,000 (Q2 2026), $700,000 (Q1 2026) and $700,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Anavex Life Sciences | 123.75 Mn | -356.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 800,000.00 |
| Mar 31, 2026 | 800,000.00 |
| Dec 31, 2025 | 700,000.00 |
| Sep 30, 2025 | 700,000.00 |
| Jun 30, 2025 | 600,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 2.40 Mn |
| Sep 30, 2024 | 2.30 Mn |
| Sep 30, 2023 | 2.50 Mn |
| Sep 30, 2022 | 2.90 Mn |
API Access
Anavex Life Sciences Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=AVXL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "AVXL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=AVXL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();